The World Endometriosis Society (WES) Montpellier Consortium published the first-ever worldwide consensus statement on the management of endometriosis, addressing 69 issues.
The statement covers global considerations; the role of endometriosis organizations, support groups, centers or networks of expertise; the effect of endometriosis throughout a woman’s life (adolescence, pregnancy, and menopause); and a full range of treatment options for pain (including medical management and complementary therapies), infertility, and other symptoms related to endometriosis.
The WES Consensus emphasizes that women with endometriosis require long-term treatment and that their symptoms, lifestyle, and fertility wishes can change over time. In addition, the Consensus represents the first time that endometriosis and pelvic pain have been treated as part of the same disease continuum.
The WES is an international group of 56 individuals representing women with endometriosis and representatives from 34 medical and non-medical organizations, including the NICHD. The WES Consensus is the first to incorporate the viewpoints of those most involved—women who have endometriosis, patients’ societies, clinicians, surgeons, scientists, and representatives from pharmaceutical companies—from five continents. The Consortium members convened and conducted a thorough review of the medical literature and included conclusions based firmly on scientific evidence, with a clear acknowledgment of areas where evidence is lacking, as well as clinical experience.
Moving forward, the WES will continue to review available evidence and update the WES Montpellier Consensus Statement as research provides new information about treating and managing endometriosis. This activity will also help to identify possible future research directions and topics (PMID: 23528916).
More information is available at: http://www.nichd.nih.gov/news/resources/spotlight/Pages/041013-endometriosis.aspx.